## Abstract We assessed the clinical impact of MMPβ9 expression on longβterm survival in patients with operable nonβsmall cell lung cancer (NSCLC). Primary tumors of 143 consecutive patients with NSCLC resected completely and without overt distant metastases (pT1β4, pN0β2, M0, R0) were examined for
Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer
β Scribed by Tokujiro Yano; Akira Haro; Tsukihisa Yoshida; Yosuke Morodomi; Kensaku Ito; Yasunori Shikada; Fumihiro Shoji; Riichiroh Maruyama; Yoshihiko Maehara
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 132 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Increased production of immunosuppressive interleukin-10 (IL-10) by non-small cell lung cancer (NSCLC) and increased serum IL-10 concentrations in NSCLC-patients have recently been correlated to reduced survival. We earlier demonstrated suppression of IL-2 secretion in whole blood cell cultures of N
## Abstract ## Background The purpose of the present study was to assess the value of matrix metalloproteinase (MMP)β2 and MMPβ9 expression and other potential prognostic factors in predicting the clinical outcome of patients after definitive surgery for pathologic stage IA nonβsmall cell lung can
## Abstract ## Background Deregulation of microRNAs (miRNAs) plays important roles in tumor progression. The aim of this study was to investigate miRβ21 expression in serum of nonβsmall cell lung cancer (NSCLC) and its correlation with prognosis of NSCLC patients. ## Methods Dysregulated miRNAs